Aussie university halts trials of skin cancer drug whose developer has four retractions

Retraction Watch

An Australian university has put a hold on trials of an experimental drug for skin cancer whose main developer has been dogged by charges of research misconduct for several years.

The Australian Broadcasting Corporation is reporting that the University of New South Wales has suspended trials of the drug, DZ13, while it investigates the work of Levon Khachigian, who is leading the studies.

According to the news organization, Khachigian and his group were cleared by the school in two prior inquiries. However, additional accusations of misconduct — specifically involving image manipulation and misuse — prompted a third investigation.

We’ve found four retractions of Khachigian’s studies, from the Journal of Biological Chemistry and Biochemical and Biophysical Research Communications, between 2009 and 2010 (before the launch of Retraction Watch).

They are:

View original post 465 more words

TLS Detox Kit

TLS Detox Kit What Makes the TLS® Detox Kit Unique?The TLS Detox Kit combines four of our most popular products to support your health, wellness and weight loss. Shed pounds and bodily waste with the TLS Detox kit and save over 28%!The NutriClean® System &md... See details

Trackbacks

  1. […] Aussie university halts trials of skin cancer drug whose developer has four retractions (healthsciencewatch.wordpress.com) […]

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: